PYRIMIDINE GLUCOPYRANOSIDES
19
5
-Cyano-6-(2-furyl)-2-(methylthio)pyrimidin-4(3H)one (2d): yield 53%;
1
ꢀ
mp 245–247 C; H NMR (DMSO-d ) d 12.30 (bs, exchangeable with D O, 1H),
6
2
8
C H N O S: C, 51.49; H, 3.02; N, 18.02. Found: C, 51.34; H, 2.91; N, 17.96.
.16 (m, 1H), 7.62 (m, 1H), 6.85 (m, 1H), 2.63 (s, 3H). Analysis. Calcd for
10
7
3 2
Nucleosides 3a-d and 4a,b,d. A solution of 2,3,4,6-tetra-O-acetyl-a-D-
glucopyranosyl bromide (4.5 g, 11 mmol) in acetone (30 mL) was added to a
solution of 2a-d (10 mmol) in aqueous KOH (1.5 M, 7 mL, 10.5 mmol). The
mixture was stirred at 23 C for 6–12 h until a TLC analysis (silica gel,
ꢀ
ether=chloroform, 1:1) showed the absence of 2a-d. Concentration on a
rotary evaporator followed by silica gel chromatography of the residue
eluting with hexanes=ether=chloroform (1:2:2) gave 3a-d, which was eluted
first, and 4a,b,d. Compounds 3 and 4 were crystallized from 95% ethanol
ꢀ
and dried at 50 C=1 mmHg.
4
-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyloxy)-5-cyano-2-methyl-
ꢀ
25
1
thio-6-phenylpyrimidine (3a): yield 60%; mp 145–147 C; [a] 46.2; H
D
NMR (CDCl ) ( 8.04 (m, 2H), 7.50 (m, 3H), 6.20 (d, J ¼ 7.6 Hz, 1H), 5.36 (m,
3
2
1
5
H), 5.21 (m, 1H), 4.24 (m, 2H), 3.99 (m, 1H), 2.63 (s, 3H), 2.04–2.08 (4s,
2H). High resolution FAB-MS. Calcd for C H N O S (M þ 1) m=z
þ
26
28
3
10
74.1495, observed m=z 574.1500. Analysis. Calcd for C H N O SÁH O:
26
27
3
10
2
C, 52.74; H, 4.90; N, 7.09. Found: C, 52.89; H, 4.72; N, 7.07.
4
-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyloxy)-5-cyano-2-methyl-
ꢀ
25
D
1
thio-6-p-tolyl)pyrimidine (3b): yield 55%; mp 138–140 C; ½aꢁ 32.2; H
NMR (CDCl ) d 7.98 (d, J ¼ 8.0 Hz, 2H), 7.33 (d, J ¼ 8.0 Hz, 1H), 6.13 (d,
3
J ¼ 9.6 Hz, 1H), 5.60 (m, 1H), 5.48 (m, 1H), 5.19 (m, 1H), 4.17 (m, 3H), 2.63
(
C, 55.19; H, 4.97; N, 7.15. Found: C, 55.06; H, 4.85; N, 7.11.
s, 3H), 2.29 (s, 3H), 2.04–2.08 (4s, 12H). Analysis. Calcd for C H N O S:
27
29
3
10
4
-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyloxy)-5-cyano-2-methyl-
ꢀ
25
1
thio-6-(2-naphthyl)pyrimidine (3c): yield 55%; mp 135–137 C; ½aꢁ 28.6; H
D
NMR (CDCl ) d 8.57 (s, 1H), 8.08 (m, 4H), 7.65 (m, 2H), 6.61 (d,
3
J ¼ 11.6 Hz, 1H), 5.65 (m, 1H), 5.23 (m, 1H), 5.08 (m, 1H), 4.41 (m, 1H), 4.24
(
C H N O S: C, 57.78; H, 4.69; N, 6.74. Found: C, 57.70; H, 4.56; N, 6.74.
m, 1H), 4.08 (m, 1H), 2.70 (s, 3H), 2.04–2.08 (4s, 12H). Analysis. Calcd for
30
29
3
10
4
-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyloxy)-5-cyano-6-(2-furyl)-
ꢀ
25
1
2
-methylthio)pyrimidine (3d): yield 60%; mp 142–144 C; ½aꢁ 35.9;
H
D
NMR (CDCl ) d 7.75 (m, 1H), 7.63 (m, 1H), 6.62 (m, 1H), 6.17 (d,
3
J ¼ 7.6 Hz, 1H), 5.36 (m, 2H), 5.20 (m, 1H), 4.25 (m, 1H), 4.17 (m, 1H),
3
.95 (m, 1H), 2.60 (s, 3H), 2.04–2.08 (4s, 12H). High resolution FAB-MS.
þ
Calcd for C H N O S (M þ 1) m=z 564.1288, observed m=z 564.1302.
24
26
3 11
Analysis. Calcd for C H N O S: C, 51.15; H, 4.47; N, 7.46. Found: C,
3 11
24
25
5
1.08; H, 4.29; N, 7.47.
3
-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-5-cyano-2-methylthio-
ꢀ
25
1
6
-phenylpyrimidine (4a): yield 10%; mp 230–232 C; ½aꢁ 51.2; H NMR
D
(
CDCl ) d 8.11 (m, 2H), 7.55 (m, 3H), 6.57 (d, J ¼ 9.2 Hz, 1H), 6.18 (m, 1H),
3
5
.42 (m, 1H), 5.26 (m, 1H), 4.25 (m, 2H), 3.97 (m, 1H), 2.73 (s, 3H), 1.96–2.10